ライフサイエンスツールの世界市場の評価：タイプ別、技術別、製品別、エンドユーザー別、地域別、機会、予測（2016年～2030年）

世界のライフサイエンスツールの市場規模は、2022年の1,512億8,000万米ドルから2030年に3,156億6,000万米ドルに達し、2023年～2030年の予測期間にCAGRで9.63%の成長が予測されています。バイオ医薬品企業による先進治療の創出に向けた投資の増加、新しい医薬品や治療法へのニーズの高まり、フローサイトメーター、分光計、顕微鏡、クロマトグラフィカラム、核酸処理装置などの器具の急速な採用、がん、糖尿病、甲状腺疾患などの慢性疾患の流行などの要因が、市場を牽引しています。

当レポートでは、世界のライフサイエンスツール市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界のライフサイエンスツール市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界のライフサイエンスツール市場の見通し（2016年～2030年）

• 市場規模と予測
  • 金額
  • 数量
• タイプ別
  • 器具
  • 消耗品
  • サービス
• 技術別
  • ゲノミクス
  • プロテオミクス
  • 細胞生物学技術
  • 実験用品
  • その他
• 製品別
  • 細胞培養システム・3D細胞培養
  • 液体クロマトグラフィ
  • 質量分析法
  • フローサイトメトリー
  • クローニング・ゲノムエンジニアリング
  • 顕微鏡検査
  • 次世代シーケンシング
  • PCR・qPCR
  • 核酸の調製
  • 核酸マイクロアレイ
  • サンガーシーケンシング
  • トランスフェクション機器・遺伝子デリバリー技術
  • 核磁気共鳴（NMR）
  • その他
• エンドユーザー別
  • 医療
  • 政府・学術機関
  • バイオ医薬品企業
  • 産業用途
  • その他
• 地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ
• 市場シェア：企業別（2022年）

第6章 世界のライフサイエンスツール市場の見通し：地域別（2016年～2030年）

• 北米
  • タイプ別
  • 技術別
  • 製品別
  • エンドユーザー別
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド
• 南米
  • ブラジル
  • メキシコ
  • アルゼンチン
• アジア太平洋
  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第7章 市場マッピング（2022年）

• タイプ別
• 技術別
• エンドユーザー別
• 製品別
• 地域別

第8章 マクロ環境と業界構造

• 需給の分析
• 輸出入の分析 - 数量と金額
• サプライ/バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第9章 市場力学

• 成長促進要因
• 成長抑制要因（課題、抑制要因）

第10章 規制の枠組みとイノベーション

• 臨床試験
• 特許の情勢
• 規制当局の承認
• イノベーション/最新技術

第11章 主要企業情勢

• マーケットリーダー上位5社の競合マトリックス
• マーケットリーダー上位5社の市場収益分析（2022年）
• 合併と買収/合弁事業（該当する場合）
• SWOT分析（市場参入企業5社向け）
• 特許分析（該当する場合）

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

• Becton, Dickinson, and Company
• Agilent Technologies Inc.
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories Inc.
• Merck KGaA
• GE Healthcare
• Bruker Corporation
• Qiagen NV
• Danaher Corporation
• Abbott Laboratories Inc.
• Shimadzu Corporation
• Hitachi, Ltd.
• Oxford Instruments plc
• Zeiss International

第15章 戦略的推奨事項

第16章 当社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 2. Global Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 3. Global Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 4. Global Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 5. Global Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 6. Global Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 7. Global Life Science Tools Market Share, By Region, In USD Billion, 2016-2030F
• Figure 8. North America Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 9. North America Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 10. North America Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 11. North America Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 12. North America Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 13. North America Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 14. North America Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
• Figure 15. United States Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 16. United States Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 17. United States Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 18. United States Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 19. United States Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 20. United States Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 21. Canada Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 22. Canada Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 23. Canada Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 24. Canada Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 25. Canada Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 26. Canada Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 27. Mexico Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 28. Mexico Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 29. Mexico Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 30. Mexico Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 31. Mexico Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 32. Mexico Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 33. Europe Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 34. Europe Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 35. Europe Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 36. Europe Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 37. Europe Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 38. Europe Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 39. Europe Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
• Figure 40. Germany Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 41. Germany Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 42. Germany Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 43. Germany Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 44. Germany Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 45. Germany Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 46. France Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 47. France Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 48. France Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 49. France Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 50. France Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 51. France Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 52. Italy Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 53. Italy Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 54. Italy Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 55. Italy Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 56. Italy Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 57. Italy Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 58. United Kingdom Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 59. United Kingdom Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 60. United Kingdom Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 61. United Kingdom Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 62. United Kingdom Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 63. United Kingdom Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 64. Russia Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 65. Russia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 66. Russia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 67. Russia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 68. Russia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 69. Russia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 70. Netherlands Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 71. Netherlands Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 72. Netherlands Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 73. Netherlands Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 74. Netherlands Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 75. Netherlands Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 76. Spain Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 77. Spain Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 78. Spain Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 79. Spain Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 80. Spain Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 81. Spain Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 82. Turkey Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 83. Turkey Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 84. Turkey Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 85. Turkey Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 86. Turkey Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 87. Turkey Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 88. Poland Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 89. Poland Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 90. Poland Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 91. Poland Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 92. Poland Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 93. Poland Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 94. South America Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 95. South America Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 96. South America Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 97. South America Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 98. South America Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 99. South America Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 100. South America Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
• Figure 101. Brazil Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 102. Brazil Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 103. Brazil Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 104. Brazil Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 105. Brazil Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 106. Brazil Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 107. Argentina Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 108. Argentina Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 109. Argentina Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 110. Argentina Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 111. Argentina Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 112. Argentina Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 113. Asia-Pacific Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 114. Asia-Pacific Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 115. Asia-Pacific Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 116. Asia-Pacific Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 117. Asia-Pacific Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 118. Asia-Pacific Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 119. Asia-Pacific Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
• Figure 120. India Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 121. India Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 122. India Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 123. India Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 124. India Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 125. India Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 126. China Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 127. China Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 128. China Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 129. China Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 130. China Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 131. China Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 132. Japan Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 133. Japan Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 134. Japan Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 135. Japan Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 136. Japan Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 137. Japan Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 138. Australia Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 139. Australia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 140. Australia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 141. Australia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 142. Australia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 143. Australia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 144. Vietnam Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 145. Vietnam Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 146. Vietnam Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 147. Vietnam Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 148. Vietnam Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 149. Vietnam Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 150. South Korea Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 151. South Korea Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 152. South Korea Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 153. South Korea Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 154. South Korea Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 155. South Korea Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 156. Indonesia Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 157. Indonesia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 158. Indonesia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 159. Indonesia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 160. Indonesia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 161. Indonesia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 162. Philippines Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 163. Philippines Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 164. Philippines Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 165. Philippines Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 166. Philippines Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 167. Philippines Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 168. Middle East & Africa Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 169. Middle East & Africa Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 170. Middle East & Africa Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 171. Middle East & Africa Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 172. Middle East & Africa Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 173. Middle East & Africa Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 174. Middle East & Africa Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
• Figure 175. Saudi Arabia Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 176. Saudi Arabia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 177. Saudi Arabia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 178. Saudi Arabia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 179. Saudi Arabia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 180. Saudi Arabia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 181. UAE Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 182. UAE Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 183. UAE Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 184. UAE Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 185. UAE Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 186. UAE Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 187. South Africa Life Science Tools Market, By Value, In USD Billion, 2016-2030F
• Figure 188. South Africa Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
• Figure 189. South Africa Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
• Figure 190. South Africa Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
• Figure 191. South Africa Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
• Figure 192. South Africa Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
• Figure 193. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022
• Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2022
• Figure 195. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2022
• Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2022
• Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022

Global Life Science Tools market size was valued at USD 151.28 billion in 2022 which is expected to reach USD 315.66 billion in 2030 with a CAGR of 9.63% for the forecast period between 2023 and 2030. The rapid development of life sciences tools and technologies such as gene sequencing, mass spectroscopy, chromatography, nuclear magnetic resonance (NMR), and other varied goods is contributing to innovation.

Additionally, the market is being driven by factors such as increasing investments by biopharmaceutical companies for the creation of advanced therapies, increasing need for novel medicines and treatments, rapid adoption of instruments such as flow cytometers, spectrometers, microscopes, chromatography columns, nucleic acid processing equipment and increasing prevalence of chronic diseases such as cancer, diabetes, thyroid disorders and many others.

The development of molecular diagnostic techniques such as digital droplet PCR, next-generation sequencing (NGS), and genome-wide sequencing has led to the introduction of DNA testing in clinical settings. For instance, Illumina, a global leader in DNA sequencing, and Genoscreen, a genomics company announced their partnership in October 2022 to speed up ending tuberculosis globally. This collaboration aims to enhance resources and skills in nations greatly affected by tuberculosis, such as India, to improve the efficiency of identifying and fighting against multidrug-resistant TB.

Increasing Demand for Biopharmaceuticals

The growing need for biologics, which often utilize recombinant DNA technology, is expected to fuel the expansion of the life science tools market. Biopharmaceuticals offer advantages such as increased efficacy, reduced adverse effects, minimized risk of drug interactions and improved patient outcomes. To meet the increasing demand and enhance the production of biological treatments, the life science industry is currently focusing on advanced analytical models such as predictive analytics. These cutting-edge innovations are being facilitated by significant technological improvements such as laboratory upgrades, strategic advancements, and operational optimizations. The demand for biopharmaceutical products has increased due to their enhanced safety, effectiveness, and ability to cure previously untreatable medical conditions.

Rapid Technological Advancements

Technological advancements have led to the growing utilization of various tools in the field, such as next sequencers, PCR (Polymerase Chain Reaction) and qPCR (quantitative polymerase chain reaction) machines, flow cytometers, spectrometers, microscopes, chromatography columns, nucleic acid processing equipment, and cell biology instruments. These advancements have had a significant impact on the integration of DNA assays in clinical settings, specifically in molecular diagnostic techniques like digital droplet PCR, NGS, and genome-wide sequencing. These methods have improved accuracy, timeframe, and reproducibility. To effectively harness the therapeutic potential of circulating nucleic acids, it is crucial to have an efficient extraction process.

Becton , Dickinson and Company (BD), a prominent global medical technology company, and Labcorp, a premier life sciences company, announced a strategic collaboration in August 2022. The collaboration aims to establish a framework for the development, production, marketing, and commercialization of companion diagnostics (CDx) based on flow cytometry. These CDx solutions are designed to complement the administration of potentially life-altering therapies for cancer and similar diseases.

Healthcare Sector is Experiencing Rapid Growth

The healthcare sector emerged as the leading contributor to the market value in 2022 and is expected to exhibit significant growth throughout the forecast period. This segment encompasses clinics, hospitals, community centers, diagnostic laboratories, and physician offices. The increasing adoption of proteomic and genomic workflows in hospitals for the diagnosis and treatment of various clinical abnormalities is predicted to drive market growth. The healthcare sector's expansion is primarily attributed to the extensive utilization and demand for tissue diagnostic solutions in hospitals. Clinicians are increasingly opting for tissue-based diagnostic tests over conventional methods due to their quick turnaround time. The integration of genomic sequencing in hospitals and clinical settings is predicted to improve patient care and reduce healthcare costs. This development is expected to drive the rapid growth of the healthcare sector. Furthermore, advancements in tools and equipment have significantly enhanced the accuracy of complex medical procedures in hospitals. The precision and reliability of medical diagnostic outcomes largely rely on the laboratory tools utilized for analysis, which positively impacts the expansion of the market.

For Instance, in January 2023, QIAGEN entered into an exclusive strategic agreement with Helix, a population genomics company based in California. According to the recently disclosed agreement, QIAGEN will have exclusive rights to market and handle contracts for Helix's companion diagnostic services within the United States. This collaboration will utilize the Helix Laboratory Platform, which has received the pioneering de novo class II authorization from the U.S. Food & Drug Administration for a comprehensive exome sequencing platform.

Growth of Cell and Gene Therapies is Propelling Market Growth

The utilization of genomic technologies on a global scale is on the rise, leading to advancements in diagnostic tests and procedures for various diseases and driving the growth of the market. A recent example is the commercial launch of a new molecular polymerase chain reaction (PCR) assay for the monkeypox virus by Becton, Dickinson, and Company (BD) and CerTest Biotec in September 2022, targeting both the United States and global markets. It is important to note that this PCR assay is currently intended for research purposes only. With the introduction of such innovative products, the market is expected to experience robust growth throughout the projected period. A comprehensive understanding of cell biology has emerged as an asset in laboratory workflows, creating new opportunities for market expansion. Furthermore, scientists in the life science field are keen to adopt cutting-edge instruments, which is anticipated to further strengthen this segment. Companies such as Cytiva, BioTek Instruments, Horizon Discovery, and Seahorse Bioscience are introducing instruments related to cell analysis, cell biology and imaging. The demand for tools and equipment is being propelled by the rising research and development activities conducted by prominent industrial companies.

A notable example is the strategic partnership between Haihe and EdiGene Laboratory, announced in January 2022, aimed at developing platform technologies and stem regenerative cell treatments. This collaboration focuses on exploring advanced biomarkers to enhance quality control in stem cell production.

Impact of COVID-19

The COVID-19 pandemic has had a significant impact on the life science tools industry and their respective supply chains worldwide. This disruption can be attributed to several factors, including the scarcity of raw materials and labor, as well as interruptions in the transportation of these materials across regions. As a result, there has been a shortage of critical medical supplies in different parts of the world, including molecular and immunoassay kits, digital solutions, life-support machines, and drugs. The COVID-19 pandemic had spurred a competitive race among manufacturers to create rapid diagnostics for the detection of SARS-CoV-2 virus, resulting in remarkable advancements and breakthroughs in terms of innovative solutions. These tests utilize various methods such as PCR for detecting the SARS-CoV-2 nucleic material, nucleic acid hybridization-related techniques, or serological and immunological assays for detecting antibodies produced in response to the virus.

For instance, in December 2021, Siemens Healthineers obtained emergency use authorization from the FDA for its 'Clinitest', a rapid COVID -19 antigen self-test, that can be self-administered by individuals aged 14 and above.

Key Players Landscape and Outlook

The market is characterized by strong competition as numerous players offer similar products. These players are consistently expanding their product portfolios and introducing new platforms through extensive research and development efforts to maintain their market position. Moreover, major companies are undertaking strategic initiatives such as collaborations, mergers and acquisitions, and new product launches to drive market growth and intensify competition. For example, in February 2022, Agilent Technologies, Inc. formed a partnership with Biosciences, Inc. to integrate the AVITI System with SureSelect target enrichment panels, aiming to provide customers with improved access to genomic tools. This initiative was anticipated to create fresh growth opportunities for the company.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Global Life Science Tools Market

4. Executive Summary

5. Global Life Science Tools Market Outlook, 2016-2030F

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. By Type
  • 5.2.1. Instruments
  • 5.2.2. Consumables
  • 5.2.3. Services
• 5.3. By Technology
  • 5.3.1. Genomics
  • 5.3.2. Proteomics
  • 5.3.3. Cell Biology Technology
  • 5.3.4. Lab Supplies
  • 5.3.5. Others
• 5.4. By Product
  • 5.4.1. Cell Culture Systems & 3D Cell Culture
  • 5.4.2. Liquid Chromatography
  • 5.4.3. Mass Spectrometry
  • 5.4.4. Flow Cytometry
  • 5.4.5. Cloning & Genome Engineering
  • 5.4.6. Microscopy
  • 5.4.7. Next Generation Sequencing
  • 5.4.8. PCR & qPCR
  • 5.4.9. Nucleic Acid Preparation
  • 5.4.10. Nucleic Acid Microarray
  • 5.4.11. Sanger Sequencing
  • 5.4.12. Transfection Devices & Gene Delivery Technologies
  • 5.4.13. Nuclear Magnetic Resonance (NMR)
  • 5.4.14. Others
• 5.5. By End-user
  • 5.5.1. Healthcare
    • 5.5.1.1. Hospitals
    • 5.5.1.2. Clinics
    • 5.5.1.3. Research Laboratories
    • 5.5.1.4. Diagnostic Laboratories
    • 5.5.1.5. Physician Office
    • 5.5.1.6. Community Centres
  • 5.5.2. Government & Academic Institutions
  • 5.5.3. Biopharmaceutical Company
  • 5.5.4. Industrial Applications
  • 5.5.5. Others
• 5.6. By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. South America
  • 5.6.4. Asia-Pacific
  • 5.6.5. Middle East and Africa
• 5.7. By Company Market Share (%), 2022

6. Global Life Science Tools Market Outlook, By Region, 2016-2030F

• 6.1. North America*
  • 6.1.1. By Type
    • 6.1.1.1. Instruments
    • 6.1.1.2. Consumables
    • 6.1.1.3. Services
  • 6.1.2. By Technology
    • 6.1.2.1. Genomics
    • 6.1.2.2. Proteomics
    • 6.1.2.3. Cell Biology Technology
    • 6.1.2.4. Lab Supplies
    • 6.1.2.5. Others
  • 6.1.3. By Product
    • 6.1.3.1. Cell Culture Systems & 3D Cell Culture
    • 6.1.3.2. Liquid Chromatography
    • 6.1.3.3. Mass Spectrometry
    • 6.1.3.4. Flow Cytometry
    • 6.1.3.5. Cloning & Genome Engineering
    • 6.1.3.6. Microscopy
    • 6.1.3.7. Next Generation Sequencing
    • 6.1.3.8. PCR & qPCR
    • 6.1.3.9. Nucleic Acid Preparation
    • 6.1.3.10. Nucleic Acid Microarray
    • 6.1.3.11. Sanger Sequencing
    • 6.1.3.12. Transfection Devices & Gene Delivery Technologies
    • 6.1.3.13. Nuclear Magnetic Resonance (NMR)
    • 6.1.3.14. Others
  • 6.1.4. By End-user
    • 6.1.4.1. Healthcare
    • 6.1.4.1.1. Hospitals
    • 6.1.4.1.2. Clinics
    • 6.1.4.1.3. Research Laboratories
    • 6.1.4.1.4. Diagnostic Laboratories
    • 6.1.4.1.5. Physician Office
    • 6.1.4.1.6. Community Centres
    • 6.1.4.2. Government & Academic Institutions
    • 6.1.4.3. Biopharmaceutical Company
    • 6.1.4.4. Industrial Applications
    • 6.1.4.5. Others
  • 6.1.5. United States*
    • 6.1.5.1. By Type
    • 6.1.5.1.1. Instruments
    • 6.1.5.1.2. Consumables
    • 6.1.5.1.3. Services
    • 6.1.5.2. By Technology
    • 6.1.5.2.1. Genomics
    • 6.1.5.2.2. Proteomics
    • 6.1.5.2.3. Cell Biology Technology
    • 6.1.5.2.4. Lab Supplies
    • 6.1.5.2.5. Others
    • 6.1.5.3. By Product
    • 6.1.5.3.1. Cell Culture Systems & 3D Cell Culture
    • 6.1.5.3.2. Liquid Chromatography
    • 6.1.5.3.3. Mass Spectrometry
    • 6.1.5.3.4. Flow Cytometry
    • 6.1.5.3.5. Cloning & Genome Engineering
    • 6.1.5.3.6. Microscopy
    • 6.1.5.3.7. Next Generation Sequencing
    • 6.1.5.3.8. PCR & qPCR
    • 6.1.5.3.9. Nucleic Acid Preparation
    • 6.1.5.3.10. Nucleic Acid Microarray
    • 6.1.5.3.11. Sanger Sequencing
    • 6.1.5.3.12. Transfection Devices & Gene Delivery Technologies
    • 6.1.5.3.13. Nuclear Magnetic Resonance (NMR)
    • 6.1.5.3.14. Others
    • 6.1.5.4. By End-user
    • 6.1.5.4.1. Healthcare
    • 6.1.5.4.1.1. Hospitals
    • 6.1.5.4.1.2. Clinics
    • 6.1.5.4.1.3. Research Laboratories
    • 6.1.5.4.1.4. Diagnostic Laboratories
    • 6.1.5.4.1.5. Physician Office
    • 6.1.5.4.1.6. Community Centres
    • 6.1.5.4.2. Government & Academic Institutions
    • 6.1.5.4.3. Biopharmaceutical Company
    • 6.1.5.4.4. Industrial Applications
    • 6.1.5.4.5. Others
  • 6.1.6. Canada
  • 6.1.7. Mexico

All segments will be provided for all regions and countries covered

• 6.2. Europe
  • 6.2.1. Germany
  • 6.2.2. France
  • 6.2.3. Italy
  • 6.2.4. United Kingdom
  • 6.2.5. Russia
  • 6.2.6. Netherlands
  • 6.2.7. Spain
  • 6.2.8. Turkey
  • 6.2.9. Poland
• 6.3. South America
  • 6.3.1. Brazil
  • 6.3.2. Mexico
  • 6.3.3. Argentina
• 6.4. Asia-Pacific
  • 6.4.1. India
  • 6.4.2. China
  • 6.4.3. Japan
  • 6.4.4. Australia
  • 6.4.5. Vietnam
  • 6.4.6. South Korea
  • 6.4.7. Indonesia
  • 6.4.8. Philippines
• 6.5. Middle East & Africa
  • 6.5.1. Saudi Arabia
  • 6.5.2. UAE
  • 6.5.3. South Africa

7. Market Mapping, 2022

• 7.1. By Type
• 7.2. By Technology
• 7.3. By End-user
• 7.4. By Product
• 7.5. By Region

8. Macro Environment and Industry Structure

• 8.1. Supply Demand Analysis
• 8.2. Import Export Analysis - Volume and Value
• 8.3. Supply/Value Chain Analysis
• 8.4. PESTEL Analysis
  • 8.4.1. Political Factors
  • 8.4.2. Economic System
  • 8.4.3. Social Implications
  • 8.4.4. Technological Advancements
  • 8.4.5. Environmental Impacts
  • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 8.5. Porter's Five Forces Analysis
  • 8.5.1. Supplier Power
  • 8.5.2. Buyer Power
  • 8.5.3. Substitution Threat
  • 8.5.4. Threat from New Entrant
  • 8.5.5. Competitive Rivalry

9. Market Dynamics

• 9.1. Growth Drivers
• 9.2. Growth Inhibitors (Challenges, Restraints)

10. Regulatory Framework and Innovation

• 10.1. Clinical Trials
• 10.2. Patent Landscape
• 10.3. Regulatory Approvals
• 10.4. Innovations/Emerging Technologies

11. Key Players Landscape

• 11.1. Competition Matrix of Top Five Market Leaders
• 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
• 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 11.4. SWOT Analysis (For Five Market Players)
• 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

• 14.1. Becton, Dickinson, and Company
  • 14.1.1. Company Details
  • 14.1.2. Key Management Personnel
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As reported)
  • 14.1.5. Key Market Focus & Geographical Presence
  • 14.1.6. Recent Developments
• 14.2. Agilent Technologies Inc.
• 14.3. Illumina Inc.
• 14.4. Thermo Fisher Scientific Inc.
• 14.5. F. Hoffmann-La Roche Ltd
• 14.6. Bio-Rad Laboratories Inc.
• 14.7. Merck KGaA
• 14.8. GE Healthcare
• 14.9. Bruker Corporation
• 14.10. Qiagen NV
• 14.11. Danaher Corporation
• 14.12. Abbott Laboratories Inc.
• 14.13. Shimadzu Corporation
• 14.14. Hitachi, Ltd.
• 14.15. Oxford Instruments plc
• 14.16. Zeiss International

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer